Periodontal status of HIV-infected patients undergoing antiretroviral therapy compared to HIV-therapy naive patients: a case control study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2047-783X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Periodontal status of HIV-infected patients undergoing antiretroviral therapy compared to HIV-therapy naive patients: a case control study ; volume:17 ; number:1 ; day:30 ; month:1 ; year:2012 ; pages:1-6 ; date:12.2012
European journal of medical research ; 17, Heft 1 (30.1.2012), 1-6, 12.2012
- Urheber
- Beteiligte Personen und Organisationen
- DOI
-
10.1186/2047-783X-17-2
- URN
-
urn:nbn:de:1111-2016073148688
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Fricke, Ulrich
- Geurtsen, Werner
- Staufenbiel, Ingmar
- Rahman, Alexander
- SpringerLink (Online service)
Ähnliche Objekte (12)
Periodontal status of HIV-infected patients undergoing antiretroviral therapy compared to HIV-therapy naive patients : a case control study
Lamivudine/dolutegravir dual therapy in HIV-infected, virologically suppressed patients
Platelet activity in HIV-infected patients on abacavir-containing antiretroviral therapy
Interferon-Containing and Interferon-Free HCV Therapy for HIV-Infected Patients
Prevalence of HIV drug-resistance mutations in HIV-infected Mexican patients heavily experienced to antiretroviral therapy
Cytomegalovirus infection in HIV-infected patients in the era of combination antiretroviral therapy
Long-term outcome of lamivudine/dolutegravir dual therapy in HIV-infected, virologically suppressed patients
Dolutegravir-based anti-retroviral therapy is effective and safe in HIV–infected paediatric patients
Hepatitis B coinfection in HIV-infected patients
Subclinical kidney disease in HIV-infected patients
A multidisciplinary staff for the optimisation of therapy in HIV-infected patients treated for cancer
Survival trends in critically ill HIV-infected patients in the highly active antiretroviral therapy era
Periodontal status of HIV-infected patients undergoing antiretroviral therapy compared to HIV-therapy naive patients : a case control study
Lamivudine/dolutegravir dual therapy in HIV-infected, virologically suppressed patients
Platelet activity in HIV-infected patients on abacavir-containing antiretroviral therapy
Interferon-Containing and Interferon-Free HCV Therapy for HIV-Infected Patients
Prevalence of HIV drug-resistance mutations in HIV-infected Mexican patients heavily experienced to antiretroviral therapy
Cytomegalovirus infection in HIV-infected patients in the era of combination antiretroviral therapy
Long-term outcome of lamivudine/dolutegravir dual therapy in HIV-infected, virologically suppressed patients
Dolutegravir-based anti-retroviral therapy is effective and safe in HIV–infected paediatric patients
Hepatitis B coinfection in HIV-infected patients
Subclinical kidney disease in HIV-infected patients
A multidisciplinary staff for the optimisation of therapy in HIV-infected patients treated for cancer
Survival trends in critically ill HIV-infected patients in the highly active antiretroviral therapy era
Periodontal status of HIV-infected patients undergoing antiretroviral therapy compared to HIV-therapy naive patients : a case control study
Lamivudine/dolutegravir dual therapy in HIV-infected, virologically suppressed patients
Platelet activity in HIV-infected patients on abacavir-containing antiretroviral therapy
Interferon-Containing and Interferon-Free HCV Therapy for HIV-Infected Patients
Prevalence of HIV drug-resistance mutations in HIV-infected Mexican patients heavily experienced to antiretroviral therapy
Cytomegalovirus infection in HIV-infected patients in the era of combination antiretroviral therapy
Long-term outcome of lamivudine/dolutegravir dual therapy in HIV-infected, virologically suppressed patients
Dolutegravir-based anti-retroviral therapy is effective and safe in HIV–infected paediatric patients
Hepatitis B coinfection in HIV-infected patients
Subclinical kidney disease in HIV-infected patients
A multidisciplinary staff for the optimisation of therapy in HIV-infected patients treated for cancer